The study led by researchers at Georgia State University in the US paired carbon monoxide with the antibiotic metronidazole.
The researchers found carbon monoxide enhanced the efficacy of the antibiotic against H pylori, a type of bacteria that infects the stomach and causes peptic ulcers.
"We found that if you administer carbon monoxide together with an antibiotic called metronidazole, it can sensitise bacteria towards the same antibiotic by 25-fold," said Binghe Wang from Georgia State.
"It makes the bacteria much, much more sensitive to the antibiotic," he said.
"Most of the time, it means there is decreased sensitivity. If you can resensitise bacteria or sensitise them, then that would allow you to either use a smaller amount of antibiotic or use the same amount that would kill many, many more bacteria," he said.
Carbon monoxide is infamous for its toxicity at high concentrations, but it also has promising potential as a medical gas, researchers said.
Produced naturally in the human body, carbon monoxide is essential for survival and plays an important role in reducing inflammation, promoting cell proliferation and regulating cellular immune response to pathogens, they said.
In the study published in the journal Organic Letters, the researchers developed a prodrug system that releases three components: carbon monoxide, an antibiotic (metronidazole) and a fluorescent molecule used to monitor the release of carbon monoxide.
A prodrug is the precursor of a drug and must undergo a chemical conversion before becoming an active pharmacological agent.
This prodrug system has a three-reaction sequence and becomes active when placed in water, which sets the reaction in motion.
They studied H pylori bacteria in a culture dish and compared the effect of only the antibiotic metronidazole against the bacteria versus the prodrug system with metronidazole and carbon monoxide combined.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
